Article

AJMC® in the Press, November 19, 2021

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A piece by The Business Journals cited an article published in a supplement to The American Journal of Managed Care® (AJMC®). The article, “Utilizing Oncology Biosimilars to Minimize the Economic Burden Associated With Cancer Treatment: Managed Care Considerations,” discussed pharmacists’ role in providing consistent messaging about biosimilars to both health care professionals and patients with cancer.

A story by BestLife referenced a study published in a supplement to AJMC®, titled “The Economic Impact of Peanut Allergies.” The study addressed the direct and indirect costs related to peanut allergies, which affect an estimated 1.2% of the overall US population and about 2.5% of the pediatric population.

Related Videos
Bridgette J. Picou, LVN, ACLPN, The Well Project
Emma Achola-Kothari, PhD
Dr Emma Achola-Kothani
Dr Emma Achola-Kothari
CK Wang, MD, COTA
Eboni Price-Haywood, MD and Toni Flowers, PhD
Dr Raymond Osarogiagbon
Dr Raymond Osarogiagbon
Dr Raymond Osarogiagbon
Naim Alkhouri, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo